IMCR in the 13F filings
Immunocore HLDGS PLC · CUSIP 45258D105
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 17 Feb 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 4 listed it in both
- Shares listed
- 15,216,235
- combined, among listed positions
- Reported value
- $528m
- combined, at the quarter end
Among the 92 comparable managers: 16 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,063,055.
Managers listing IMCR in Q4 2025
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdnew position · 454,404 shares now+454,404
- Acadian Asset Management LLCexisting position · 461,830 shares now+262,333
- Citadel Advisors LLCexisting position · 234,268 shares now+192,070
- D. E. Shaw & Co.new position · 183,940 shares now+183,940
- Two Sigma Investments LPexisting position · 359,293 shares now+138,597
Reductions
- Millennium Management LLCexisting position · 911,597 shares now-354,368
- Wellington Management Group LLPexisting position · 4,693,643 shares now-87,246
- Marshall Wace LLPexisting position · 61,163 shares now-62,079
- T. Rowe Price Associates Incexisting position · 968,784 shares now-47,987
- MFS Investment Managementexisting position · 407,404 shares now-34,994
New positions and exits
New (6)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 2 | $5.9m | n.a. | n.a. |
| Q2 2021 | 1 | $5.4m | n.a. | n.a. |
| Q1 2022 | 1 | $12m | n.a. | n.a. |
| Q3 2022 | 2 | $32m | n.a. | n.a. |
| Q4 2022 | 4 | $181m | n.a. | n.a. |
| Q1 2023 | 2 | $203m | n.a. | n.a. |
| Q2 2023 | 4 | $416m | n.a. | n.a. |
| Q3 2023 | 5 | $353m | n.a. | n.a. |
| Q4 2023 | 4 | $511m | 3 | 1 |
| Q1 2024 | 6 | $609m | 4 | 1 |
| Q2 2024 | 4 | $248m | 3 | 1 |
| Q3 2024 | 4 | $259m | 4 | 0 |
| Q4 2024 | 4 | $232m | 2 | 2 |
| Q1 2025 | 5 | $238m | 3 | 2 |
| Q2 2025 | 5 | $193m | 1 | 4 |
| Q3 2025 | 4 | $205m | 1 | 3 |
| Q4 2025 | 5 | $214m | 16 | 8 |
| Q1 2026 | 4 | $182m | 19 | 8 |
| Q2 2026 | 4 | $248m | 15 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IMCR and GILD →IMCR and AMGN →IMCR and ARGX →Choose a stock to compare with IMCR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IMCR, latest filings →Back to the 13F Explorer →